2024-517002-28-00撤回1 期
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.
Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L., Vall D Hebron Institute Of Oncology1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2024年11月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 发起方
- 入组人数
- 8
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
scientific information
Scientific
Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.graft-versus-host disease2024-517002-28-01Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L., Vall D Hebron Institute Of Oncology8
进行中（未招募）
1 期
Safety study of DIPG treatment with autologous dendritic cells pulsed with lysated allegenic tumor linesDiffuse intrinsic pontine glioma (DIPG)MedDRA version: 19.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-003362-84-ESFundació Sant Joan de Déu
尚未招募
1 期
A Vaccine for preventing PregnancyCTRI/2017/09/009934Indian Council of Medical Research
已完成
不适用
A safety and immunogenicity phase 1 trial with an adjuvated TB subunit vaccine (Ag85B - ESAT-6 + IC31) administered in PPD positive volunteers at 0 and 2 monthsPrevention10028440TuberculosisNL-OMON30684Statens Serum Institut20
已完成
不适用
Phase I clinical trial to assess safety and immunogenicity of an MVA-based influenza H5 vaccine in healthy adultsflu10047438InfluenzaNL-OMON38408Erasmus MC, Universitair Medisch Centrum Rotterdam27